AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Working Group On Civilian Biodefense Warns Tularemia Could Be Threat.(Brief Article)
2001 JUL 4 - (NewsRx.com & NewsRx.net) --
The Working Group on Civilian Biodefense, an expert panel convened by the Center for Civilian Biodefense Studies at the Johns Hopkins University Bloomberg School of Public Health, says that the highly infectious disease tularemia, also known as rabbit fever, could pose serious consequences if used as a biological weapon.
In underscoring the importance of this issue, the paper cites a World Health Organization study that projected estimates of 250,000 illnesses and 19,000 deaths in the event that a mass-casualty tularemia biological weapon were used against a modern city of five million people.
In this latest report, published in the June 6, 2001, issue of the Journal of the American Medical Association, the Hopkins Working Group recommends medical and public health guidelines and policies to minimize the consequences from an attack.
"This report highlights the need to address the nation's preparedness and response to possible bioweapon-induced epidemics," says the report's lead author, David T. Dennis, MD, MPH, a member of the Hopkins Working Group and a senior researcher with the Division of Vector-Borne Infectious Diseases at the U.S. Centers for Disease Control and Prevention (CDC).
A tularemia-based bioweapon would trigger cases of pneumonia, pleuritis, and lymph node disease within three to five days after exposure, according to the paper. Unless treated with effective antibiotics, the disease could lead to serious illness including possible respiratory failure, shock, or death.
"Diagnostic testing capabilities are available for tularemia, but they are not widely available. Effective antibiotic treatment regimens also exist for tularemia, but they are not the antibiotics clinicians would likely prescribe for routine treatment of pneumonia. Given the rarity of tularemia and the non-specific features of the disease, clinicians are not likely to order the needed diagnostic test, nor begin the proper antibiotics until some time into an epidemic," explains Dennis.
- New Journal, BIOSECURITY: Biodefense Strategy, Practice, and Science Announces...
- Press release article from: Business Wire March 15, 2002 700+ words
...liebertpub.com/bsp) Dr. O'Toole is currently the Director of the Johns Hopkins University Center for Civilian Biodefense Strategies, which is sponsored by the Hopkins Schools of Public Health and Medicine. Dr. Inglesby is deputy...
- Covalent Group Signs $1.0 Million Contract to Study Vaccine Against Plague.
- Press release article from: PR Newswire May 5, 2004 700+ words
...personnel as well as civilian populations in the case of a bioterrorist attack with Y. pestis. The Working Group on Civilian Biodefense wrote in their Consensus Statement on Plague as a Biological Weapon, 'The availability of Y. pestis...
- Plague: from natural disease to bioterrorism.
- Magazine article from: Baylor University Medical Center Proceedings Riedel, Stefan April 1, 2005 700+ words
...subsequent identification of relevant references published prior to 1966. The consensus statement of the Working Group on Civilian Biodefense regarding plague was the basis of the final risk assessment and evaluation of the current threat (3...
- $1M contract signed to study vaccine against plague.
- Newspaper article from: Health & Medicine Week June 7, 2004 700+ words
...personnel as well as civilian populations in the case of a bioterrorist attack with Y. pestis. The Working Group on Civilian Biodefense wrote in their Consensus Statement on Plague as a Biological Weapon, 'The availability of Y. pestis...
- FDA Advisory Panel Recommends Approval of CIPRO(R) for Treating Anthrax...
- Press release article from: PR Newswire July 28, 2000 700+ words
...antibiotic treatment with ciprofloxacin or other fluoroquinolone therapy has been recommended by The Working Group on Civilian Biodefense(1). The safety and efficacy data submitted for CIPRO(R) in treating anthrax exposure was based...
- Tularemia Could Be Bioweapons Threat.(Brief Article)
- Magazine article from: Journal of Environmental Health September 1, 2001 700+ words
...danger if used as a biological weapon, according to a report by the Working Group on Civilian Biodefense. The working group was convened by the Center for Civilian Biodefense Studies at the Johns Hopkins University Bloomberg School of Public...
- Bioterrorism: issues affecting health care workers. (Journal Club).
- Magazine article from: Nephrology Nursing Journal Zarifian, April Brooks, Deborah Dutka, Paula McCarley, Patricia B. Bremer, Kimberly F. February 1, 2002 700+ words
...for ongoing updates and recommendations. Working Group on Civilian Biodefense, American Medical Association. (2001...consensus statement on this topic by the Working Group on Civilian Biodefense that was published in JAMA and is posted...
- Cipro May Be First Drug Approved for Anthrax.(Brief Article)
- Magazine article from: Family Practice News WANG, JENNIFER M. September 1, 2000 700+ words
...according to recommendations published by the Working Group on Civilian Biodefense (JAMA 28l[18]:1735-45, 1999...consultant to the panel, and a member of the Working Group on Civilian Biodefense. Sixty macaques were separated into groups...
Source: HighBeam Research, Working Group On Civilian Biodefense Warns Tularemia Could Be...